Tscan Therapeutics Inc (TCRX) Directors and Executive Officers

Officers & Directors

Tscan Therapeutics Inc. Executives and Directors

- Gavin MacBeath, Ph.D. - Chief Executive Officer and Director (Principal Executive Officer)
- Jason A. Amello - Chief Financial Officer (Principal Financial and Accounting Officer)
- Stephen Biggar - Director
- R. Keith Woods - Director
- Gabriela Gruia - Director
- Barbara Klencke - Director
- Timothy Barberich - Director,

Tscan Therapeutics Inc currently has 142 employees.

News about Tscan Therapeutics Inc Key Personnel

TScan Therapeutics Raises $150 Million in Upsized Public Offering to Accelerate Breakthrough Cancer Therapies

TScan Therapeutics Raises $150 Million in Upsized Public Offering to Advance Cancer Therapies
TScan Therapeutics, a clinical-stage biopharmaceutical company specializing in T cell receptor (TCR)-engineered T cell therapies (TCR-T) for cancer treatment, recently announced the pricing of an underwritten public offering. The company is offering 2,472,581 shares of its voting common stock at a public offering price of $7.1300 per share. Additionally, pre-funded warrants to purchase up to 18,577,419 shares of voting common stock are being sold at $7.1299 per warrant. TScan has also granted the underwriters a 30-day option to purchase up to an additional 3,157,500 shares of voting common stock at the public of...